COHANCE.BO
Cohance Lifesciences Limited$430.40
Jun 02, 2026
Revenue · FY
$22.69B
Net income
$1.79B
FY 2026
EPS · diluted
$4.68
EBITDA
$4.27B
Explain this page
Arphra AIPlain-English read on Cohance Lifesciences Limited’s valuationPro
Sentiment analysis
Our news and social sentiment analysis is included with Pro.
- Scored news timeline and topic mix
- Social sentiment trend
- Aggregate sentiment vs price